US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Pharmaceuticals Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Pharmaceuticals Company Reports Industry Research & Market Reports

1  2  3    5    7  8  9  10  
Oramed Pharmaceuticals, Inc. (ORMP) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
PlasmaTech Biopharmaceuticals, Inc. (PTBI) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Sophiris Bio, Inc. (SPHS) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review
6/16/2015 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 125
Sarepta Therapeutics, Inc. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sarepta Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Sirnaomics, Inc. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Sirnaomics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Tekmira Pharmaceuticals Corp. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Tekmira Pharmaceuticals Corp.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Novavax, Inc. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Novavax, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Colby Pharmaceutical Company - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Colby Pharmaceutical Company’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Pulmatrix, Inc. - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Pulmatrix, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Chipscreen Biosciences Ltd - Product Pipeline Review - 2015
6/17/2015 | published by: Global Markets Direct
... focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Chipscreen Biosciences Ltd’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration ...  |  read more...
USD 1,500
Coris BioConcept - Product Pipeline Analysis, 2015 Update
6/16/2015 | published by: GlobalData
... cryptosporidium and giardia, escherichia coli, and rotavirus among others. It also detects influenza A & B viruses, legionella, respiratory adenovirus, rotavirus and adenovirus, rotavirus and respiratory syncytial virus. Its molecular pathogens include leishmania, trypanosome cruzi ...  |  read more...
USD 750
BTG Plc (BTG) - Product Pipeline Analysis, 2015 Update
6/24/2015 | published by: GlobalData
... treatment of snake envenomation and toxicity related with medicines used for heart conditions and cancerinterventional vascular products for treating patients with severe blood clots and varicose veins in the great saphenous vein system of the ...  |  read more...
USD 750
Bristol-Myers Squibb Company (BMY) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Bachem Holding AG (BANB) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Biocon Limited (BIOCON) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Mitsubishi Tanabe Pharma Corporation (4508) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Ono Pharmaceutical Co., Ltd. (4528) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Patheon Inc. - Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ...  |  read more...
USD 125
Kobayashi Pharmaceutical Co Ltd (4967) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 300
PT Kalbe Farma Tbk (KLBF) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
KYORIN Holdings, Inc. (4569) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Yuhan Corporation (000100) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review
6/23/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 300
1  2  3    5    7  8  9  10